Kintara Therapeutics Inc (KTRA)
0.1506
0.00 (0.00%)
USD |
NASDAQ |
May 10, 11:43
Kintara Therapeutics Max Drawdown (5Y): 99.96% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| April 30, 2024 | 99.96% |
| March 31, 2024 | 99.96% |
| February 29, 2024 | 99.96% |
| January 31, 2024 | 99.95% |
| December 31, 2023 | 99.94% |
| November 30, 2023 | 99.88% |
| October 31, 2023 | 99.72% |
| September 30, 2023 | 99.62% |
| August 31, 2023 | 99.62% |
| July 31, 2023 | 99.62% |
| June 30, 2023 | 99.62% |
| May 31, 2023 | 99.62% |
| April 30, 2023 | 99.62% |
| March 31, 2023 | 99.62% |
| February 28, 2023 | 99.62% |
| January 31, 2023 | 99.62% |
| December 31, 2022 | 99.62% |
| November 30, 2022 | 99.62% |
| October 31, 2022 | 99.62% |
| September 30, 2022 | 99.62% |
| August 31, 2022 | 99.62% |
| July 31, 2022 | 99.62% |
| June 30, 2022 | 99.62% |
| May 31, 2022 | 99.62% |
| April 30, 2022 | 99.62% |
| Date | Value |
|---|---|
| March 31, 2022 | 99.62% |
| February 28, 2022 | 99.62% |
| January 31, 2022 | 99.62% |
| December 31, 2021 | 99.62% |
| November 30, 2021 | 99.62% |
| October 31, 2021 | 99.62% |
| September 30, 2021 | 99.62% |
| August 31, 2021 | 99.62% |
| July 31, 2021 | 99.62% |
| June 30, 2021 | 99.62% |
| May 31, 2021 | 99.62% |
| April 30, 2021 | 99.62% |
| March 31, 2021 | 99.62% |
| February 28, 2021 | 99.62% |
| January 31, 2021 | 99.62% |
| December 31, 2020 | 99.62% |
| November 30, 2020 | 99.62% |
| October 31, 2020 | 99.62% |
| September 30, 2020 | 99.62% |
| August 31, 2020 | 99.62% |
| July 31, 2020 | 99.62% |
| June 30, 2020 | 99.62% |
| May 31, 2020 | 99.62% |
| April 30, 2020 | 99.62% |
| March 31, 2020 | 99.62% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
98.37%
Minimum
May 2019
99.96%
Maximum
Mar 2024
99.60%
Average
99.62%
Median
Mar 2020
Max Drawdown (5Y) Benchmarks
| ARCA biopharma Inc | 98.78% |
| Shockwave Medical Inc | 64.92% |
| Vanda Pharmaceuticals Inc | 89.11% |
| Heron Therapeutics Inc | 98.09% |
| Asensus Surgical Inc | 99.68% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -82.71 |
| Beta (5Y) | 0.4155 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 121.8% |
| Historical Sharpe Ratio (5Y) | -0.6409 |
| Historical Sortino (5Y) | -1.268 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 48.77% |